Lubiprostone SPE2D2-25-R-0022
Summary
AI-generated · Sep 04, 2025A national requirements contract to supply Lubiprostone capsules (24 mcg and 8 mcg) in 60-count bottles is being planned. The award will be unrestricted and fully competitive, on a firm-fixed-price, requirements basis, with a 1-year base period and four 1-year option periods. The contract will establish a national supply source to provide these items to DoD, VA, IHS, and the Bureau of Prisons through DLA and VA prime vendor programs.
This is a commercial item solicitation under FAR Part 12, open to all sources. Proposals from all interested parties will be considered. The solicitation will be posted on DIBBS and SAM.gov, with annual usage estimates shown in the Schedule of Supplies. Respondents should monitor those sites for the solicitation and related changes.
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Lubiprostone Capsules. Procurement details follow. Lubiprostone 24MCG Capsules and Lubiprostone 8 MCG Capsules in 60 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is September of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
From Presolicitation posted on Sep 03, 2025The Defense Logistics Agency is listing a solicitation for a national requirements contract for Lubiprostone Capsules. Procurement details follow. Lubiprostone 24MCG Capsules and Lubiprostone 8 MCG Capsules in 60 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current solicitation date is October of 2025.
From Solicitation posted on Oct 03, 2025The Defense Logistics Agency is listing a solicitation for a national requirements contract for Lubiprostone Capsules. Procurement details follow. Lubiprostone 24MCG Capsules and Lubiprostone 8 MCG Capsules in 60 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current solicitation date is October of 2025.
From Solicitation posted on Nov 05, 2025Notice history
3-
Presolicitation Posted Sep 03, 2025
-
Solicitation Posted Oct 03, 2025View changes (3)
- Description: Description was updated
- Notice Type: Presolicitation → Solicitation
- Response Deadline: Not set → Nov 03, 2025
-
Solicitation LATEST Posted Nov 05, 2025View changes (1)
- Response Deadline: Nov 03, 2025 → Nov 17, 2025
Details
Award Information
Not yet awarded
Contacts
Phone
Phone